Espicom


The Pharmaceutical Market: Gabon

Published 20 April 2015

  • 58 pages
  • Instant access to your report online and PDF format through your account library
  • Includes 3 free updated quarterly reports
 
$1,295.00
The Pharmaceutical Market: Gabon

Table of Contents

BMI Industry View
7
SWOT
9
Political
10
Economic
11
Operational Risk
12
Industry Forecast
13
Pharmaceutical Market Forecast
13
Table: Pharmaceutical Sales, Historical Data And Forecasts (Gabon 2011-2019)
14
Healthcare Market Forecast
15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Gabon 2011-2019)
17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Gabon 2011-2019)
18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Gabon 2011-2019)
18
Gabon - Domestic Manufacturing Output To Remain Minimal
19
Macroeconomic Forecasts
21
Economic Analysis
21
Table: Economic Activity (Gabon 2010-2019)
24
Industry Risk Reward Indicies
25
Middle East And Africa Risk/Reward Index
25
Gabon Risk/Reward Index
32
Rewards
32
Risks
32
Market Overview
33
Industry Trends And Developments
35
Epidemiology
35
Regulatory Development
42
Regulatory Environment
42
Intellectual Property Regime
43
Competitive Landscape
44
Pharmaceutical Sector
44
Demographic Forecast
46
Table: Population Headline Indicators (Gabon 1990-2025)
47
Table: Key Population Ratios (Gabon 1990-2025)
47
Table: Urban/Rural Population & Life Expectancy (Gabon 1990-2025)
48
Table: Population By Age Group (Gabon 1990-2025)
48
Table: Population By Age Group % (Gabon 1990-2025)
49
Glossary
51
Methodology
53
Pharmaceutical Expenditure Forecast Model
53
Healthcare Expenditure Forecast Model
53
Notes On Methodology
54
Risk/Reward Index Methodology
55
Index Overview
56
Table: Pharmaceutical Risk/Reward Index Indicators
56
Indicator Weightings
57

The Gabon Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Gabon Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Gabon pharmaceutical and healthcare industry.

Key Benefits

  • Benchmark BMI's pharmaceutical and healthcare market forecasts for Gabon, to test other views - a key input for successful budgeting and strategic business planning in the Gabonese pharmaceutical and healthcare market.
  • Target business opportunities and risks in the Gabonese pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Gabon.
  • Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.

Coverage

BMI Industry View

An at-a-glance perspective on the latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The pharmaceuticals and healthcare SWOT outlines strategic factors that affect the basic assumptions underpinning BMI’s forecast analysis, and taken together with BMI’s political, economic and business environment SWOTs, it gives a complete overview of market climate.

BMI Industry Forecast Scenario

Industry forecasts to end-2019 for all key indicators, supported by explicit assumptions, plus analysis of key downside risks to the main forecasts:

  • Healthcare: Total healthcare expenditure (USDbn), healthcare expenditure (% of GDP), healthcare expenditure per capita (USD), hospital beds, doctors, and birth & mortality rates (all per ‘000 population).
  • Pharmaceutical Market: Drug expenditure in USDbn, % of GDP and per capita (USD).
  • Patented Drug Market: Prescription drug sales (USDbn & % of total sales).
  • Generic Drug Market: Generic product sales (USDbn), generic sales (% of total sales).
  • OTC Drug Market: OTC sales (USDbn & % of total sales).
  • Macroeconomic Forecasts: Nominal and real GDP, % real GDP growth, % private consumption growth, % industrial output growth, % consumer price index, % GDP price deflator, exports, imports, trade balance, current account balance, foreign direct investment, exchange rate against USD, government expenditure and external debt.

BMI’s Pharmaceuticals and Healthcare Risk Reward Index

BMI’s Risk Reward Index provides investors (both national and multinational) looking for opportunities in the region with a clear country-comparative assessment of the market’s risks and potential rewards. Each of the country markets are scored using a sophisticated model that includes more than 40 industry, economic and demographic data points to provide indices of highest to lowest appeal to investors, with each position explained.

Market Summary

A snapshot of key market characteristics, including total size of the pharmaceuticals and healthcare segments, growth drivers, leading therapeutic areas and the competitive landscape

Industry Developments

A focus on government healthcare reforms, epidemiological trends, mergers and acquisitions, product launches, market entries, FDI activity, R&D, biotechnology, clinical trials and supply chain issues.

Regulatory Regime

Details of the industry regulatory framework and key legislation covering the licensing of new products/services, pricing and reimbursements, intellectual property, taxation and advertising, as well as analysis of the overall regulatory burden.

Competitive Landscape

The competitive landscape section provides comparative company analyses and index by USD sales and % share of total sales – for the total pharmaceutical sector, as well as the OTC, generics and distribution sub-sectors.

Company Profiles*

Examines the competitive positioning and short- to medium-term business strategies of key industry players. Strategy is examined within the context of BMI’s industry forecasts, our macroeconomic views and our understanding of the wider competitive landscape to generate Company SWOT analyses. The latest financial and operating statistics and key company developments are also incorporated within the company profiles, enabling a full evaluation of recent company performance and future growth prospects.

*Company profiles are not available for every country. Those reports instead contain information on the current activities of prominent companies operating in the market.

secure
Benefit from discounts when you add multiple products to your basket
2 Products SAVE 10%
3 Products SAVE 15%
4 Products SAVE 20%
5 Products SAVE 25%
6 Products SAVE 30%
7 - 20 Products SAVE 35%
21 Products or more SAVE 40%